Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score.
Okada Y, Usui Y, Hayashi H, Nishikubo M, Toubai T, Uchida N, Tanaka M, Onizuka M, Takahashi S, Doki N, Uehara Y, Maruyama Y, Ishiwata K, Kawakita T, Sawa M, Eto T, Ishimaru F, Kato K, Fukuda T, Atsuta Y, Kanda J, Yakushijin K, Nakasone H. Okada Y, et al. Among authors: nakasone h. Blood Adv. 2024 Mar 26;8(6):1359-1368. doi: 10.1182/bloodadvances.2023011837. Blood Adv. 2024. PMID: 38163321 Free PMC article.
Association between serum high-molecular-weight adiponectin level and the severity of chronic graft-versus-host disease in allogeneic stem cell transplantation recipients.
Nakasone H, Binh PN, Yamazaki R, Tanaka Y, Sakamoto K, Ashizawa M, Sato M, Terasako K, Kimura S, Kikuchi M, Kako S, Okuda S, Oshima K, Tanihara A, Nishida J, Abe Y, Kanda Y. Nakasone H, et al. Blood. 2011 Mar 24;117(12):3469-72. doi: 10.1182/blood-2010-10-316109. Epub 2011 Jan 21. Blood. 2011. PMID: 21258011 Free article.
Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
Tanaka Y, Nakasone H, Yamazaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Sato M, Terasako K, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. Tanaka Y, et al. Among authors: nakasone h. J Clin Immunol. 2012 Dec;32(6):1340-52. doi: 10.1007/s10875-012-9729-5. Epub 2012 Jul 5. J Clin Immunol. 2012. PMID: 22763862
A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.
Nakasone H, Kanda J, Yano S, Atsuta Y, Ago H, Fukuda T, Kakihana K, Adachi T, Yujiri T, Taniguchi S, Taguchi J, Morishima Y, Nagamura T, Sakamaki H, Mori T, Murata M; GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation. Nakasone H, et al. Transpl Int. 2013 Jun;26(6):631-9. doi: 10.1111/tri.12093. Epub 2013 Apr 1. Transpl Int. 2013. PMID: 23551210 Free article.
Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation.
Yamazaki R, Nakasone H, Tanaka Y, Sato M, Terasako K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. Yamazaki R, et al. Among authors: nakasone h. Biol Blood Marrow Transplant. 2013 Jul;19(7):1013-20. doi: 10.1016/j.bbmt.2013.04.007. Epub 2013 Apr 10. Biol Blood Marrow Transplant. 2013. PMID: 23583826 Free article.
Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Murata M, Nakasone H, Kanda J, Nakane T, Furukawa T, Fukuda T, Mori T, Taniguchi S, Eto T, Ohashi K, Hino M, Inoue M, Ogawa H, Atsuta Y, Nagamura-Inoue T, Yabe H, Morishima Y, Sakamaki H, Suzuki R. Murata M, et al. Among authors: nakasone h. Biol Blood Marrow Transplant. 2013 Aug;19(8):1183-9. doi: 10.1016/j.bbmt.2013.05.003. Epub 2013 May 12. Biol Blood Marrow Transplant. 2013. PMID: 23676716 Free article.
Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies.
Kawamura K, Kikuchi M, Terasako K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Kimura S, Nakasone H, Okuda S, Yamazaki R, Kanda J, Kako S, Tanaka Y, Tanihara A, Nishida J, Kanda Y. Kawamura K, et al. Among authors: nakasone h. Transfus Apher Sci. 2013 Oct;49(2):334-40. doi: 10.1016/j.transci.2013.06.005. Epub 2013 Jun 27. Transfus Apher Sci. 2013. PMID: 23810219 Clinical Trial.
The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL.
Machishima T, Kako S, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Ashizawa M, Terasako K, Kimura S, Kikuchi M, Nakasone H, Kanda J, Yamazaki R, Nishida J, Kanda Y. Machishima T, et al. Among authors: nakasone h. Clin Transplant. 2013 Sep-Oct;27(5):749-56. doi: 10.1111/ctr.12213. Epub 2013 Aug 20. Clin Transplant. 2013. PMID: 24033855
Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides.
Sakamoto K, Nakasone H, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Ashizawa M, Sato M, Terasako-Saito K, Machishima T, Kimura S, Kikuchi M, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y. Sakamoto K, et al. Among authors: nakasone h. PLoS One. 2013 Sep 5;8(9):e73754. doi: 10.1371/journal.pone.0073754. eCollection 2013. PLoS One. 2013. PMID: 24040054 Free PMC article.
242 results